just a reminder to everyone. The FDA meeting was flagged as...

just a reminder to everyone.

The FDA meeting was flagged as happening in Q3. Now that's a three month window and who knows what nominal date they'd put in the gantt chart.

In the end the meeting was slightly later than expected. They put out an ann to manage expectations but beginning of October is barely late, so it didn't worry me at all and was nowhere near any putative list of "management disappointments".

Still it means that the next set of wheels may have started turning slightly later than expected so Q4 for a deal may never have been on.

I would love to see an ann that showed that the Ph III precursors had been completed. That would be very good news. While a deal ann will come at us out of the blue, I hope we keep seeing anns that show that the other company activities are going well.